Sfoglia per AUTORE
PIVA C
Collezione ASL Biella

  

Items : 13

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2023 Nov;62(11):1440-1450. doi: 10.1080/0284186X.2023.2259597. Epub 2023 Nov 7.

2023
ASL Biella
ASL Torino 4

Fiorino C; Cozzarini C; Kirchheiner K; Di Muzio N; Sanguineti G; Munoz F; Vavassori V; Piva C; Pavarini M; Valdagni R; Rago L; Ferrari P; Noris Chiorda B; Gatti M; Girelli G; Magli A; Cante D; Villa E; Faiella A; Garibaldi E; Avuzzi B; Waskiewicz JM; Rancati T; Spampinato S;

Predictors of Patient-Reported decline in Social activity 2-years after WPRT for prostate cancer in Radiotherapy and Oncology

2023
ASL Torino 4
ASL Biella

Pavarini M; Girelli G; Villa E; Avuzzi B; Bresolin A; Garibaldi E; Faiella A; Magli A; Cante D; Waskiewicz JM; Statuto T; Ferella L; Noris Chiorda B; Rago L; Ferrari P; Gatti M; Piva C; Rancati T; Valdagni R; Vavassori VL; Munoz F; Sanguineti G; Di Muzio NG; Fiorino C; Cozzarini C;

Persistent urinary symptoms and long-term quality of life after prostate cancer radiotherapy in Radiotherapy and Oncology

2023
ASL Torino 4
ASL Biella

Spampinato S; Waskiewicz JM; Avuzzi B; Garibaldi E; Faiella A; Villa E; Magli A; Cante D; Girelli G; Gatti M; Ferella L; Noris Chiorda B; Rago L; Ferrari P; Piva C; Maddalena P; Tiziana R; Valdagni R; Vavassori V; Munoz F; Sanguineti G; Di Muzio N; Kirchheiner K; Fiorino C; Cozzarini C;

Bladder dose surface maps identify subregions associated to late toxicities after prostate cancer RT in Radiotherapy and Oncology

2023
ASL Torino 4
ASL Biella

Gioscio E; Cicchetti A; Iacovacci J; Spampinato S; Waskiewicz JM; Avuzzi B; Garibaldi E; Villa E; Magli A; Cante D; Girelli G; Gatti M; Ferella L; Noris Chiorda B; Ferrari P; Piva C; Pavarini M; Valdagni R; Vavassori V; Munoz F; Fiorino C; Cozzarini C; Rancati T;

Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation in Radiotherapy and Oncology

2023
ASL Torino 4
ASL Biella

Pavarini M; Rago L; Munoz F; Magli A; Cante D; Girelli G; Bresolin A; Noris Chiorda B; Waskiewicz JM; Avuzzi B; Garibaldi E; Faiella A; Villa E; Ferrari P; Ferella L; Piva C; Statuto T; Gatti M; Rancati T; Valdagni R; Vavassori VL; Sanguineti G; Di Muzio NG; Fiorino C; Cozzarini C;

ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY in Physica Medica

2023
ASL Biella
ASL Torino 4

Spampinato S; Waskiewicz JM; Avuzzi B; Garibaldi E; Faiella A; Villa E; Magli A; Cante D; Girelli G; Gatti M; Noris Chiorda B; Rago L; Ferrari P; Piva C; Pavarini M; Rancati T; Valdagni R; Vavassori V; Munoz F; Sanguineti G; Di Muzio N; Kirchheiner K; Fiorino C; Cozzarini C;

USE DOSE OF SURFACE MAPS TO IDENTIFY BLADDER SUBREGIONS ASSOCIATED WITH LATE TOXICITIES AFTER PROSTATE CANCER RADIOTHERAPY in Physica Medica

2023
ASL Biella
ASL Torino 4

Gioscio E; Cicchetti A; Iacovacci J; Spampinato S; Avuzzi B; Noris Chiorda B; Badenchini F; Waskiewicz JM; Garibaldi E; Villa E; Magli A; Cante D; Girelli G; Gatti M; Farella L; Ferrari P; Piva C; Pavarini M; Valdagni R; Vavassori V; Munoz F; Fiorino C; Cozzarini C; Rancati T;

Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer in Radiotherapy and Oncology

2022
ASL Torino 4
ASL Biella

Cozzarini C; Fiorino C; Di Muzio N; Sanguineti G; Munoz F; Vavassori V; Valdagni R; Rancati T; Badenchini F; Piva C; Bresolin A; Ferrari P; Rago L; Noris Chiorda B; Ferella L; Gatti M; Girelli G; Cante D; Garibaldi E; Avuzzi B; Magli A; Waskiewicz JM; Villa E; Gebbia A; Faiella A;

Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4
ASL Biella

Cante D; Avuzzi B; Waskiewicz JM; Faiella A; Villa E; Ferella L; Garibaldi E; Magli A; Chiorda BN; Girelli G; Olivetta E; Piva C; Gatti M; Ferrari P; Moretti E; Sanguineti G; Vavassori V; Munoz F; Rancati T; Badenchini F; Bresolin A; Valdagni R; Muzio ND; Fiorino C; Cozzarini C;

Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4
ASL Biella

Chiorda BN; Munoz F; Sanguineti G; Cante D; Waskiewicz JM; Avuzzi B; Vavassori V; Gatti M; Girelli G; Magli A; Pastorino A; Ferella L; Faiella A; Piva C; Ferrari P; Villa E; Farina B; Moretti E; Rancati T; Badenchini F; Bresolin A; Valdagni R; Muzio ND; Fiorino C; Cozzarini C;

Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4
ASL Biella

Garibaldi E; Faiella A; Villa E; Magli A; Cante D; Avuzzi B; Waskiewicz JM; Ferella L; Chiorda BN; Girelli G; Pastorino A; Piva C; Gatti M; Ferrari P; Maggio A; Olivetta E; Sanguineti G; Vavassori V; Munoz F; Rancati T; Badenchini F; Bresolin A; Valdagni R; Muzio ND; Fiorino C; Cozzarini C;

Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer in Radiotherapy and Oncology

2021
ASL Torino 4
ASL Biella

Cozzarini C; Sanguineti G; Vavassori V; Munoz F; Avuzzi B; Garibaldi E; Cante D; Waskiewicz JM; Magli A; Faiella A; Villa E; Ferella L; Gatti M; chiorda BN; Piva C; Ferrari P; Rancati T; Badenchini F; Girelli G; Moretti E; Valdagni R; Bresolin A; Muzio ND; Fiorino C;

New trends in neoadjuvant therapy for rectal cancer in Techniques in Coloproctology

2017
ASL Torino 4
AOU Città della Salute di Torino
ASL Biella

Panier Suffat L; Piva C; Sciacero P; Cante D; Bombaci S; Vellani G; La Porta R; Scapino B; Rosato L; Testa V; Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P; Rapetti L; Salvai A; Perinotti R; et alii...